A5100306040- Breast Implant and Reconstruction
- Breast Cancer Treatment Studies
- Breast Lesions and Carcinomas
Nanjing Medical University
2024-2025
Introduction Given that axillary lymph node dissection (ALND) may not contribute to local control or survival and could lead increased arm morbidity, de-escalation procedures have replaced ALND in patients achieving pathologic complete response (apCR) after neoadjuvant systemic therapy (NST). However, the application of targeted biopsy, one procedures, remains limited due a lack long-term follow-up studies. Methods analysis This prospective, single-arm, open-label, non-inferiority,...
Introduction Sentinel lymph node biopsy (SLNB) is a standard procedure for patients with clinically assessed negative axillary nodes (cN0) during early-stage breast cancer (EBC). However, the majority of EBC have pathological confirmation sentinel (SLN), and surgery inevitably associated postoperative complications. Considering that SLNB has no therapeutic benefit, this trial aims to determine safety omitting in cN0 early invasive cancer. Methods analysis The OMSLNB prospective, single-arm,...